Compare Liberty Global Ltd Class C (LBTYK) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liberty Global Ltd Class C vs Zoetis Inc — how do they compare? Liberty Global Ltd Class C trades at $10.1 (market cap $3.48B), while Zoetis Inc trades at $73.57 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 8.9× Liberty Global Ltd Class C's market cap, and Zoetis Inc pays a 2.81% dividend while Liberty Global Ltd Class C pays none. Which is the better fit depends on your goals.
| LBTYK | ZTS | |
|---|---|---|
Market Cap | $3.48B | $31.14B |
Sector | Technology | Health |
52-Week High | $12.67 | $156.76 |
52-Week Low | $9.59 | $71.91 |
Enterprise Value | $10.13B | $38.70B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LBTYK trades at $10.105, up 1.15% on the day, but technical indicators signal a bearish trend. The company reported mixed quarterly earnings, with a Q1 2026 beat but Q2 2026 miss, while full-year 2025 showed a net loss of $7.14B. Positive cash flow of $264.80M in 2025 and strategic moves like the Ziggo Group spin-off planned for 2027 highlight management's focus on unlocking value. Analyst sentiment is largely bullish with 69% buy ratings, citing sum-of-the-parts potential.
The outlook hinges on execution of asset monetizations and the Ziggo listing, offering upside if successful, but persistent losses and competitive pressures pose risks. Investors should weigh the high analyst optimism against fundamental weaknesses and market volatility.
Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.
The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
